Effect of Pioglitazone on Pancreatic Steatosis and Bone Health.
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Pioglitazone (Primary)
- Indications Insulin resistance
- Focus Biomarker; Pharmacodynamics
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 24 Oct 2012 Status changed from recruiting to completed.
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.